MedPath

Comparision of Bharangyadi arka nebulisation with Kantakari arka nebulisation in Asthma in School Age Group (6 to 12years)

Not Applicable
Conditions
Health Condition 1: - Health Condition 2: J22- Unspecified acute lower respiratory infection
Registration Number
CTRI/2020/06/025649
Lead Sponsor
Principal PDEAs college of ayurved and research centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patients having classical symptoms of Tamak Shawas like cough,wheezing,dyspnea of mild to moderate degree.

2)Conscious and well oriented.

3)PEFR -60%-90%.

Exclusion Criteria

1)Sever cases of Asthma

2)Known case of acute respiratory infection like pneumonia,bronchitis,whooping cough.

3)Cough with fever and vomiting.

4)Known case of congenital heart disease.

5)Known case of chronic infection.

6)PEFR- <40%

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare efficacy of Bharangyadi arka nebulisation with Kantakari arka nebulisation with dose 2.5ml per nebulisation 8 hourly (as per req.)for 3 days on Tamak Shwasa in school age group for 3 days.Timepoint: Assessment at 0 then treatment given, then assessed after 30 min, then on 2 nd day and 3 rd day.
Secondary Outcome Measures
NameTimeMethod
To Study the adverse of drug if any.Timepoint: 3 days follow up <br/ ><br>on 1st day /8 hourly <br/ ><br>2nd day /8 hourly <br/ ><br>3rd day /8 hourly
© Copyright 2025. All Rights Reserved by MedPath